在患有食道状细胞癌的患者中,新辅助化学 (无线电) 疗法和解剖管泄漏风险
Yuzhen Xie1, Hongni Qin1, Fan Wu1
1Department of Life Sciences, College of Biotechnology, Suzhou Industrial Park Institute of Services Outsourcing, Jiangsu Province, Suzhou, China.
Cirugia y cirujanos
|July 4, 2025
概括
新辅助化学辐射疗法 (NCRT) 改善了食道癌的病理反应,但与新辅助化学疗法 (NCT) 相比,显著增加了静脉泄漏风险. 辐射剂量没有影响泄漏率.
科学领域:
- 在瘤学瘤学.
- 手术瘤学手术瘤学
- 胃肠道手术 胃肠道手术
背景情况:
- 食道癌的治疗往往涉及切除前的新辅助疗法.
- 在新辅助化学疗法 (NCT) 和新辅助化学放射疗法 (NCRT) 之间做出选择会影响结果.
- 解剖漏是术后的一个关键并发症.
研究的目的:
- 为了比较NCT和NCRT在食道癌手术后对道泄漏的效果.
- 为了评估病理完全缓解 (pCR) 和生存率的差异.
- 为了识别出解静脉泄漏的危险因素.
主要方法:
- 从三项临床研究中对222名患者进行了回顾性分析.
- 在NCRT组的113名患者和NCT组的109名患者之间的比较.
- 在新辅助治疗后进行标准化手术切除 (Ivor-Lewis或McKeown).
主要成果:
- NCRT组显示出较高的pCR率 (39.8%对5.5%) 和30天死亡率 (2.7%对0%).
- 在NCRT组中,解剖器泄漏的发生率明显高于NCRT组 (28.3%对5.5%).
- 多变量分析证实NCRT是道泄漏的重要危险因素 (OR 7.28).
结论:
- 虽然NCRT增强了病理反应,但也增加了静脉漏的风险.
- NCT提供了较低的静脉流泄漏风险.
- 辐射剂量-体积参数与静脉漏无关.
相关概念视频
Esophageal Strictures-I: Introduction
277
Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
277
Barrett Esophagus-II: Clinical Manifestations and Management
315
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
315
Esophageal Varices-II: Clinical Features and Management
147
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
147
Esophageal Strictures-II: Clinical Features and Management
162
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
162
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
329
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
329
Barrett Esophagus-I: Introduction
219
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
219


